Company news
Quest PharmaTech Inc. news in 2018
Quest PharmaTech Inc.'s news releases, calls and decks from 2018, newest first.
Quest PharmaTech Adopts Amendment to By-laws Requiring Advance Notice of Nomination of Directors
December 19, 2018
Quest PharmaTech Announces Adoption of Shareholder Rights Plan
December 3, 2018
Quest PharmaTech Signs License Agreement with OncoCare Therapeutics to Develop and Commercialize Targeted Cancer Therapy Technology in the U.S.
November 28, 2018
Madenco Biosciences Announces Strategic Decision to Drop Consumer Health Products and Focus on Pharmaceutical Product Development
July 20, 2018
Abstract Describing Use of Oregovomab in Pancreatic Cancer to be Published in JCO as Part of ASCO 2018 Meeting
June 1, 2018
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer
May 14, 2018
OncoQuest Completes US$6 Million Private Placement
February 6, 2018
Madenco Biosciences Announces Licensing Agreement for Patented EGF Wound Healing Technology
January 3, 2018